The Computer-Administered Neuropsychological Screen
for mild cognitive impairments
Easily assess your patient’s cognitive health.
Gain higher reimbursements with the CANS-MCI.
Preclinical Diagnosis of ADBiomarker research finds CANS-MCI performance predicts both elevated Aβ and tau. The CANS-MCI captures item-level response times at millisecond accuracy and can detect patterns of delay associated with the preclinical stage of AD. To read more about this research, click here.
Tracking "Chemo Brain"When cognitive and emotional changes associated with cancer treatment are important to evaluate, baseline data can be compared with post-treatment testing. The CANS-MCI provides the most staff-efficient, objective, longitudinal assessment of cognitive change available today.
Neurological Complications of COVID-19Brain fog associated with COVID is a disorder of executive function that makes even basic cognitive tasks complicated; memory can also be affected. The CANS-MCI measures the relevant cognitive dimensions and the influence of depression, making it exceptionally accurate for longitudinal tracking.
Concussion AssessmentThe central changes in cognitive ability due to sports concussion are memory, cognitive processing speed, and reaction time — all measured at millisecond accuracy by the CANS-MCI. Our automated test also eliminates the potential for the deliberate or unaware bias of in-person testers.